Peptides & GLP-1 drugs
Neutral overviews and verified provider pricing. Peptides and GLP-1s are listed together.
Blends
Wolverine (BPC-157 / TB-500)
A recovery blend of BPC-157 and TB-500, two synthetic peptides studied mostly in animals for tissue repair. Neither is FDA-approved, and the combination is investigational in humans.
Glow (GHK-Cu / BPC-157 / TB-500)
A skin-and-recovery blend combining the copper peptide GHK-Cu with BPC-157 and TB-500. It is not FDA-approved and is investigational in humans.
Klow (GHK-Cu / BPC-157 / TB-500 / KPV)
The Glow blend plus KPV, an anti-inflammatory peptide. Four synthetic or naturally derived peptides combined; not FDA-approved and investigational in humans.
CJC-1295 / Ipamorelin
A growth-hormone peptide blend pairing CJC-1295 with ipamorelin, marketed to prompt the body's own GH release. Neither is FDA-approved and the combination is investigational in humans.
Tesamorelin / Ipamorelin
A growth-hormone peptide blend pairing tesamorelin with ipamorelin, marketed for body recomposition. Tesamorelin is FDA-approved only for a narrow HIV-related use; the blend itself is investigational.
Semax / Selank
A nootropic peptide blend of Semax and Selank, developed in Russia and often sold as a nasal spray. Neither is FDA-approved and the combination is investigational in the US.
Tesamorelin / KPV
A blend pairing tesamorelin, a growth-hormone peptide, with KPV, an anti-inflammatory peptide. Tesamorelin is FDA-approved only for a narrow HIV-related use; the blend is investigational.
Cognitive
Selank
Selank is a synthetic peptide studied mainly in Russia for anxiety and cognition, not approved by the FDA.
Semax
Semax is a synthetic peptide studied for effects on cognition and neuroprotection, registered as a drug in Russia but not FDA-approved.
Growth Hormone
Sermorelin
A synthetic growth hormone-releasing hormone analog studied for its ability to stimulate the pituitary to release the body's own growth hormone.
Ipamorelin
Ipamorelin is an investigational synthetic peptide studied as a selective growth hormone secretagogue.
CJC-1295
CJC-1295 is a synthetic growth hormone-releasing hormone analog studied in early trials but not approved as a medicine.
Immune
KPV
KPV is an investigational tripeptide fragment of alpha-MSH studied in preclinical models for its anti-inflammatory properties.
LL-37
LL-37 is the human cathelicidin antimicrobial peptide, an endogenous host-defense molecule studied in research settings but not FDA-approved.
Longevity
Epithalon
Epithalon is a synthetic four-amino-acid peptide studied in aging research; it is not an approved medicine.
Glutathione
A naturally occurring antioxidant tripeptide studied for oxidative stress, liver conditions, and skin pigmentation.
Recovery & Healing
BPC-157
BPC-157 is a synthetic peptide studied in animals for tissue repair. It is not FDA-approved and remains investigational in humans.
TB-500
A synthetic peptide related to thymosin beta-4, studied in animal models for tissue repair and not approved for human use.
Sexual Health
PT-141
A melanocortin receptor agonist peptide studied for low sexual desire; FDA-approved as Vyleesi for HSDD in premenopausal women.
Kisspeptin
An investigational peptide that stimulates reproductive hormone signaling, studied in clinical trials but not FDA-approved.
Skin & Hair
Sleep
Weight Management
Semaglutide
A GLP-1 receptor agonist studied for type 2 diabetes and weight management, sold as FDA-approved branded products.
Tirzepatide
A dual GIP and GLP-1 receptor agonist, FDA-approved as Mounjaro and Zepbound and studied in weight management and metabolic conditions.
AOD-9604
AOD-9604 is an investigational synthetic peptide fragment of human growth hormone studied for effects on fat metabolism.
5-Amino-1MQ
An investigational small-molecule NNMT inhibitor studied in animals for effects on fat metabolism, with no published human trials.
MOTS-c
MOTS-c is a mitochondrial-derived peptide studied in laboratory and animal research for its role in metabolism. It is not an approved drug.
Tesamorelin
A synthetic growth-hormone-releasing hormone analog studied mainly for reducing excess abdominal fat in HIV-associated lipodystrophy.
Retatrutide
An investigational triple-receptor agonist studied for weight management and metabolic conditions. Not FDA-approved and not legally compoundable.